Dr. Marina Konopleva
Claim this profileM D Anderson Cancer Center
Studies Acute Myeloid Leukemia
Studies Myeloid Leukemia
2 reported clinical trials
3 drugs studied
Affiliated Hospitals
More about Marina Konopleva
Clinical Trial Related3 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 0 Active Clinical TrialsTreatments Marina Konopleva has experience with
- Decitabine
- Venetoclax
- Cedazuridine
Breakdown of trials Marina Konopleva has run
Acute Myeloid Leukemia
Myeloid Leukemia
Relapse
T-Lymphoblastic Leukemia/Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Marina Konopleva specialize in?
Marina Konopleva focuses on Acute Myeloid Leukemia and Myeloid Leukemia. In particular, much of their work with Acute Myeloid Leukemia has involved TP53 positive patients, or patients who are undergoing treatment.
Is Marina Konopleva currently recruiting for clinical trials?
No, Marina Konopleva is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Marina Konopleva has studied deeply?
Yes, Marina Konopleva has studied treatments such as Decitabine, Venetoclax, Cedazuridine.
What is the best way to schedule an appointment with Marina Konopleva?
Apply for one of the trials that Marina Konopleva is conducting.
What is the office address of Marina Konopleva?
The office of Marina Konopleva is located at: M D Anderson Cancer Center, Houston, Texas 77030 United States. This is the address for their practice at the M D Anderson Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.